Ghada Abuali is the Chief Operating Officer at ANGLE and responsible for driving various corporate and commercial activities and providing executive support. Dr Abuali has a PhD in cancer research from Imperial College London, an MBA from Imperial Business School, and an MSc in Molecular Diagnostics from University of Nottingham.
She has over 20 years of scientific and commercial experience in the molecular diagnostic industry.
Ghada started her career working as a medical laboratory scientist where she established and managed a CAP-certified molecular diagnostics laboratory. She then pursued a PhD with a focus on cancer gene therapy and the role of a novel cancer-specific apoptosis inducing gene specifically in renal cancer. After her PhD, she completed a postdoctoral fellowship at the Cleveland Clinic focusing on prostate cancer where she developed an ultra-sensitive, real-time PCR assay for the detection of a low frequency/rare allele mutation that significantly correlates with the progression of castration resistant prostate cancer. Her MSc, PhD, and postdoctoral research projects were all published in peer-reviewed journals with the latter published in Lancet Oncology and replicated by independent groups.
Prior to joining ANGLE in March 2020, Ghada led a successful career in various technical and commercial roles, most recently as Senior Manager at QIAGEN for OEM sales in EMEA where she managed B2B commercial relationships, consistently overachieving multimillion-dollar sales targets.
LinkedIn
Ghada has over 20 years of scientific and commercial experience in the molecular diagnostic industry.